T. Rowe Price Associates’s Humana HUM Stock Holding History

T. Rowe Price Associates’s Portfolio HUM Stock Details HUM Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$86.6M	Buy	354,418 +1,915	+0.5%	+$468K	0.01%	600
2025 Q1	$93.3M	Sell	352,503 -1,801,837	-84%	-$477M	0.01%	563
2024 Q4	$547M	Sell	2,154,340 -90,098	-4%	-$22.9M	0.06%	253
2024 Q3	$711M	Sell	2,244,438 -424,895	-16%	-$135M	0.08%	223
2024 Q2	$997M	Buy	2,669,333 +270,129	+11%	+$101M	0.12%	162
2024 Q1	$832M	Sell	2,399,204 -1,498,902	-38%	-$520M	0.1%	185
2023 Q4	$1.78B	Sell	3,898,106 -3,183,913	-45%	-$1.46B	0.24%	89
2023 Q3	$3.45B	Sell	7,082,019 -143,739	-2%	-$69.9M	0.5%	34
2023 Q2	$3.23B	Sell	7,225,758 -441,890	-6%	-$198M	0.45%	43
2023 Q1	$3.72B	Buy	7,667,648 +44,518	+0.6%	+$21.6M	0.56%	36
2022 Q4	$3.9B	Buy	7,623,130 +831,057	+12%	+$426M	0.63%	32
2022 Q3	$3.3B	Sell	6,792,073 -780,378	-10%	-$379M	0.54%	37
2022 Q2	$3.54B	Sell	7,572,451 -1,217,739	-14%	-$570M	0.45%	38
2022 Q1	$3.83B	Sell	8,790,190 -1,717,812	-16%	-$748M	0.39%	44
2021 Q4	$4.87B	Buy	10,508,002 +48,738	+0.5%	+$22.6M	0.44%	35
2021 Q3	$4.07B	Buy	10,459,264 +1,006,175	+11%	+$392M	0.38%	45
2021 Q2	$4.19B	Sell	9,453,089 -636,051	-6%	-$282M	0.39%	41
2021 Q1	$4.23B	Buy	10,089,140 +99,832	+1%	+$41.9M	0.42%	39
2020 Q4	$4.1B	Buy	9,989,308 +656,606	+7%	+$269M	0.42%	45
2020 Q3	$3.86B	Buy	9,332,702 +1,089,117	+13%	+$451M	0.45%	39
2020 Q2	$3.2B	Sell	8,243,585 -1,270,975	-13%	-$493M	0.4%	48
2020 Q1	$2.99B	Buy	9,514,560 +7,610,553	+400%	+$2.39B	0.47%	40
2019 Q4	$698M	Buy	1,904,007 +878,027	+86%	+$322M	0.09%	242
2019 Q3	$262M	Sell	1,025,980 -262,778	-20%	-$67.2M	0.04%	394
2019 Q2	$342M	Sell	1,288,758 -4,061,021	-76%	-$1.08B	0.05%	351
2019 Q1	$1.42B	Buy	5,349,779 +238,150	+5%	+$63.3M	0.21%	112
2018 Q4	$1.46B	Buy	5,111,629 +1,495,023	+41%	+$428M	0.25%	103
2018 Q3	$1.22B	Sell	3,616,606 -42,197	-1%	-$14.3M	0.18%	132
2018 Q2	$1.09B	Sell	3,658,803 -425,325	-10%	-$127M	0.17%	138
2018 Q1	$1.1B	Sell	4,084,128 -2,482,437	-38%	-$667M	0.17%	132
2017 Q4	$1.63B	Sell	6,566,565 -2,773,076	-30%	-$688M	0.26%	86
2017 Q3	$2.28B	Sell	9,339,641 -2,353,932	-20%	-$573M	0.39%	57
2017 Q2	$2.81B	Sell	11,693,573 -661,287	-5%	-$159M	0.51%	34
2017 Q1	$2.55B	Buy	12,354,860 +2,191,221	+22%	+$452M	0.48%	39
2016 Q4	$2.07B	Sell	10,163,639 -3,089,978	-23%	-$630M	0.41%	52
2016 Q3	$2.34B	Sell	13,253,617 -613,956	-4%	-$109M	0.47%	46
2016 Q2	$2.49B	Buy	13,867,573 +2,620,906	+23%	+$471M	0.53%	36
2016 Q1	$2.06B	Buy	11,246,667 +1,633,372	+17%	+$299M	0.44%	43
2015 Q4	$1.72B	Buy	9,613,295 +152,330	+2%	+$27.2M	0.36%	66
2015 Q3	$1.69B	Buy	9,460,965 +1,059,223	+13%	+$190M	0.38%	60
2015 Q2	$1.61B	Sell	8,401,742 -1,403,259	-14%	-$268M	0.33%	73
2015 Q1	$1.75B	Buy	9,805,001 +621,347	+7%	+$111M	0.36%	63
2014 Q4	$1.32B	Buy	9,183,654 +211,193	+2%	+$30.3M	0.28%	94
2014 Q3	$1.17B	Sell	8,972,461 -249,659	-3%	-$32.5M	0.26%	97
2014 Q2	$1.18B	Buy	9,222,120 +2,516,575	+38%	+$321M	0.25%	96
2014 Q1	$756M	Buy	6,705,545 +2,422,329	+57%	+$273M	0.17%	155
2013 Q4	$442M	Buy	4,283,216 +1,096,146	+34%	+$113M	0.1%	242
2013 Q3	$297M	Buy	3,187,070 +1,786,013	+127%	+$167M	0.07%	308
2013 Q2	$118M	Buy	+1,401,057	New	+$118M	0.03%	522